Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Ebola, Childhood Cancers, And Chronic Pain: IMI's New R&D Ventures

This article was originally published in Scrip

Executive Summary

Europe's Innovative Medicines Initiative (IMI) has launched two calls for proposals, one of which allots €70m ($76m) for research into Ebola, specifically the development of vaccines, treatments and diagnostic tests to improve responses to future outbreaks of Ebola or related diseases.